Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Colosimo ME and Katz ER | Altered prestarvation response in a nystatin resistant Dictyostelium discoideum mutant. | 2001 | Differentiation | pmid:11270118 |
Wilson MJ et al. | A molecular epidemiological study of sequential oral isolates of Candida albicans from terminally ill patients. | 2001 | J. Oral Pathol. Med. | pmid:11302239 |
Baca D et al. | Obstructive laryngotracheitis secondary to gentian violet exposure. | 2001 | Clin Pediatr (Phila) | pmid:11336425 |
Santelmann H et al. | Effectiveness of nystatin in polysymptomatic patients. A randomized, double-blind trial with nystatin versus placebo in general practice. | 2001 | Fam Pract | pmid:11356731 |
Chandra J et al. | Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. | 2001 | J. Dent. Res. | pmid:11379893 |
Norkin LC et al. | Association of caveolin with Chlamydia trachomatis inclusions at early and late stages of infection. | 2001 | Exp. Cell Res. | pmid:11399051 |
Tzatzarakis MN et al. | Comparison of in vitro activities of amphotericin, clotrimazole, econazole, miconazole, and nystatin against Fusarium oxysporum. | 2001 | J Environ Sci Health B | pmid:11411855 |
Worthen DR et al. | Methods for the recovery and purification of polyene antifungals. | 2001 | Drug Dev Ind Pharm | pmid:11411895 |
Boogaerts M et al. | Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients. | 2001 | J. Antimicrob. Chemother. | pmid:11418517 |
Watkinson SC | Regulation of coremium morphogenesis in Penicillium claviforme. | 1975 | J. Gen. Microbiol. | pmid:1141857 |